Comparing the efficacy and safety of faecal microbiota transplantation with bezlotoxumab in reducing the risk of recurrent [electronic resource]
Producer: 20201027Description: e031145 p. digitalISSN:- 2044-6055
- Anti-Bacterial Agents -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Bayes Theorem
- Broadly Neutralizing Antibodies -- therapeutic use
- Clostridium Infections -- physiopathology
- Diarrhea -- physiopathology
- Fecal Microbiota Transplantation
- Humans
- Network Meta-Analysis
- Recurrence
- Risk
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.